1. Home
  2. LINC vs RAPP Comparison

LINC vs RAPP Comparison

Compare LINC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LINC
  • RAPP
  • Stock Information
  • Founded
  • LINC 1946
  • RAPP 2022
  • Country
  • LINC United States
  • RAPP United States
  • Employees
  • LINC N/A
  • RAPP N/A
  • Industry
  • LINC Other Consumer Services
  • RAPP
  • Sector
  • LINC Real Estate
  • RAPP
  • Exchange
  • LINC Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • LINC 530.1M
  • RAPP 463.8M
  • IPO Year
  • LINC 2005
  • RAPP 2024
  • Fundamental
  • Price
  • LINC $17.18
  • RAPP $10.15
  • Analyst Decision
  • LINC Strong Buy
  • RAPP Strong Buy
  • Analyst Count
  • LINC 4
  • RAPP 5
  • Target Price
  • LINC $20.25
  • RAPP $35.00
  • AVG Volume (30 Days)
  • LINC 261.3K
  • RAPP 259.3K
  • Earning Date
  • LINC 05-05-2025
  • RAPP 05-10-2025
  • Dividend Yield
  • LINC N/A
  • RAPP N/A
  • EPS Growth
  • LINC N/A
  • RAPP N/A
  • EPS
  • LINC 0.32
  • RAPP N/A
  • Revenue
  • LINC $440,064,000.00
  • RAPP N/A
  • Revenue This Year
  • LINC $12.08
  • RAPP N/A
  • Revenue Next Year
  • LINC $8.63
  • RAPP N/A
  • P/E Ratio
  • LINC $53.69
  • RAPP N/A
  • Revenue Growth
  • LINC 16.40
  • RAPP N/A
  • 52 Week Low
  • LINC $9.51
  • RAPP $6.43
  • 52 Week High
  • LINC $19.79
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • LINC 57.78
  • RAPP N/A
  • Support Level
  • LINC $16.11
  • RAPP N/A
  • Resistance Level
  • LINC $17.40
  • RAPP N/A
  • Average True Range (ATR)
  • LINC 1.00
  • RAPP 0.00
  • MACD
  • LINC 0.17
  • RAPP 0.00
  • Stochastic Oscillator
  • LINC 83.57
  • RAPP 0.00

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: